NASDAQ

Viridian Therapeutics, Inc. (VRDN)

♥ 439 Thanks from members

Live price chart, market sentiment, and community perspectives for Viridian Therapeutics, Inc. (NASDAQ: VRDN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Biotechnology and PharmaceuticalsFounder: Viridian Therapeutics TeamLeadership: Susan Stewart (CEO)Leadership: Barrie J. Levitt (Chief Medical Officer)Holder: Fidelity Management and ResearchHolder: BlackRock Inc.Holder: RA Capital ManagementVRDN-001VRDN-003IGF-1R Inhibitors for Thyroid Eye Disease#VRDN#Viridian Therapeutics#NASDAQ VRDN#Biotech Stock#Thyroid Eye Disease